1. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Lenci, I.; Aragri, M.; Polilli, E.; Fiorentino, G.; Pace Palitti, V.; Bruzzone, B.; Paolucci, S.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Niero, F.; Micheli, V.; Nicolini, L.A.; Marenco, S.; Bertoli, A.; Maida, I.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017) Authors: Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies. Issue 1 (16th February 2017) Authors: Di Maio, V.C.; Cento, V.; Lenci, I.; Aragri, M.; Barbaliscia, S.; Francioso, S.; Paolucci, S.; Melis, M.; Verucchi, G.; Masetti, C.; Coppola, N.; Magni, C.F.; Micheli, V.; Pollicino, T.; Ruggiero, T.; Landonio, S.; Mancon, A.; Starace, M.; De Leonardis, F.; Santopaolo, F. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing. Issue 1 (February 2018) Authors: Ruggiero, T.; Cento, V.; Aragri, M.; Arosio, M.; Baldanti, F.; Brunetto, M.; Bruzzone, B.; Boeri, E.; Cavallone, D.; Coppola, N.; Di Stefano, M.; Ghisetti, V.; Callegaro, A.P.; Capobianchi, M.R.; Caudai, C.; Cuomo, N.; Galli, S.; Galmozzi, E.; Garbuglia, A.R.; Gennari, W. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017) Authors: Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life. (October 2017) Authors: Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Magni, C.F.; Paolucci, S.; Babudieri, S.; Siciliano, M.; Pasquazzi, C.; Ciancio, A.; Perno, C.F.; Ceccherini-Silberstein, F. Journal: Clinical microbiology and infection Issue: Volume 23:Number 10(2017) Page Start: 777.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy. Issue 1 (16th February 2017) Authors: Di Maio, V.C.; Barbaliscia, S.; Lenci, I.; Teti, E.; Antonucci, F.P.; Cento, V.; Aragri, M.; Paolucci, S.; Bruzzone, B.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Polilli, E.; Pasquazzi, C.; Pace Palitti, V.; Magni, C.F.; Micheli, V.; Di Biagio, A.; Sticchi, L.; Melis, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy. (February 2015) Authors: Boglione, L.; De Nicolò, A.; Cardellino, C.S.; Ruggiero, T.; Ghisetti, V.; Cariti, G.; Di Perri, G.; D'Avolio, A. Journal: Clinical microbiology and infection Issue: Volume 21:Number 2(2015:Feb.) Page Start: 205.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network. Issue 1 (16th February 2017) Authors: Cento, V.; Barbaliscia, S.; Di Maio, V.C.; Masetti, C.; Minichini, C.; Magni, C.F.; Micheli, V.; Marenco, S.; Nicolini, L.A.; Bruzzone, B.; Troshina, Y.; Baiguera, C.; Dentone, C.; Calvaruso, V.; Paolucci, S.; Melis, M.; Aragri, M.; Bertoli, A.; Lenci, I.; Landonio, S. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗